EdaƱo, Eufemia P.
HRN: 22-49-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/18/2023
01/24/2023
IV
600mg
Q8
DM Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes